M&A Snapshot
- Deal volume in 1st half of 2023 was down from 2022, which was a record year.
- Multiples are trending upwards, reaching 2021 values.
- Non-essential specialties, such as plastics, dermatology and medical devices are selling for higher multiples.
- Dermatology experienced one of the highest increases in multiples since 2020.
- The higher the EBITDA the higher the multiple.